Organogenesis Holdings Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORGO research report →
Companyorganogenesis.com
Organogenesis Holdings Inc. , a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved.
- CEO
- Gary S. Gillheeney
- IPO
- 2017
- Employees
- 869
- HQ
- Canton, MA, US
Price Chart
Valuation
- Market Cap
- $324.90M
- P/E
- -1136.22
- P/S
- 0.63
- P/B
- 0.85
- EV/EBITDA
- 6.90
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 70.41%
- Op Margin
- 2.14%
- Net Margin
- -0.06%
- ROE
- -0.07%
- ROIC
- -0.16%
Growth & Income
- Revenue
- $563.03M · 16.80%
- Net Income
- $37.03M · 4201.05%
- EPS
- $0.16 · 2353.52%
- Op Income
- $55.87M
- FCF YoY
- -685.73%
Performance & Tape
- 52W High
- $7.08
- 52W Low
- $2.04
- 50D MA
- $2.45
- 200D MA
- $3.99
- Beta
- 1.31
- Avg Volume
- 1.51M
Get TickerSpark's AI analysis on ORGO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 10, 25 | Grow Brian | other | 958 |
| Jan 10, 25 | Grow Brian | other | 958 |
| Mar 9, 26 | Leibowitz Arthur S | buy | 5,000 |
| Mar 9, 26 | Driscoll Michael Joseph | buy | 10,000 |
| Mar 1, 26 | Cavorsi Robert | other | 700 |
| Feb 18, 26 | Montecalvo Antonio S. | other | 11,330 |
| Feb 18, 26 | Montecalvo Antonio S. | other | 3,778 |
| Feb 18, 26 | Gillheeney Gary S. | other | 188,856 |
| Feb 18, 26 | Gillheeney Gary S. | other | 91,311 |
| Feb 18, 26 | Grow Brian | other | 48,818 |
Our ORGO Coverage
View all →
Want a deeper read on ORGO?
Generate a full analyst-grade report — bull / bear case, price targets, valuation depth, and a complete financial breakdown.